Lawrence Saperstein

Lawrence Saperstein, MD is an Associate Professor of Radiology and Biomedical Imaging at Yale School of Medicine and Chief of Nuclear Medicine. He specializes in nuclear medicine, focusing on molecular imaging technologies to advance prostate cancer detection. His research evaluates the clinical impact of PSMA-PET imaging in prostate cancer recurrence, emphasizing cost-effectiveness and diagnostic accuracy.

• Education: MD from Duke University School of Medicine (1993), Residency in Diagnostic Radiology at Columbia Presbyterian Medical Center (2000), Fellowship in Nuclear Radiology (2001).
• Certifications: Board Certified in Nuclear Medicine (2011) and Diagnostic Radiology (2000).

His clinical expertise includes thyroid imaging, bone scans, and hyperthermic intraperitoneal chemotherapy (HIPEC). He collaborates with departments like the Center for Gastrointestinal Cancers and Oligometastatic Cancer Program. Recent work highlights PSMA-targeted imaging’s role in guiding treatment decisions for biochemically recurrent prostate cancer. Ongoing projects explore AI applications in PET imaging for obese patients.